CoChat

Pyk2 activates the NLRP3 inflammasome by directly phosphorylating ASC and contributes to inflammasome-dependent peritonitis

Chung, I-Che, OuYang, Chun-Nan, Yuan, Sheng-Ning, Li, Hsin-Pai, Chen, Jeng-Ting, Shieh, Hui-Ru, Chen, Yu-Jen, Ojcius, David M., Chu, Ching-Liang, Yu, Jau-Song, Chang, Yu-Sun, Chen, Lih-Chyang · 2016 · Scientific Reports
Cited by 89

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The inflammasome adaptor protein, ASC, contributes to both innate immune responses and inflammatory diseases via self-oligomerization, which leads to the activation of the protease, caspase-1. Here, we report that the cytosolic tyrosine kinases, FAK and Pyk2, are differentially involved in NLRP3 and AIM2 inflammasome activation. The inhibition of FAK and Pyk2 with RNA interference or chemical inhibitors dramatically abolished ASC oligomerization, caspase-1 activation, and IL-1β secretion in response to NLRP3 or AIM2 stimulation. Pyk2 is phosphorylated by the kinase Syk and relocalizes to the ASC specks upon NLRP3 inflammasome activation. Pyk2, but not FAK, could directly phosphorylate ASC at Tyr146, and only the phosphorylated ASC could participate in speck formation and trigger IL-1β secretion. Moreover, the clinical-trial-tested Pyk2/FAK dual inhibitor PF-562271 reduced monosodium urate-mediated peritonitis, a disease model used for studying the consequences of NLRP3 activation. Our results suggest that although Pyk2 and FAK are involved in inflammasome activation, only Pyk2 directly phosphorylates ASC and brings ASC into an oligomerization-competent state by allowing Tyr146 phosphorylation to participate ASC speck formation and subsequent NLRP3 inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep36214

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 28

  1. Cai, X. et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156, 1207–1222, doi: 10.1016/j.cell.2014.01.063 (2014). · DOI · Paper page
  2. Lu, B. et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670–674, doi: 10.1038/nature11290 (2012). · DOI · Paper page
  3. Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12, 408–415, doi: 10.1038/ni.2022 (2011). · DOI · Paper page
  4. Hara, H. et al. Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat Immunol 14, 1247–1255, doi: 10.1038/ni.2749 (2013). · DOI · Paper page
  5. Lin, Y. C. et al. Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization. J Leukoc Biol, doi: 10.1189/jlb.3HI0814-371RR (2015). · DOI · Paper page
  6. Gross, O. et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459, 433–436, doi: 10.1038/nature07965 (2009). · DOI · Paper page
  7. Shio, M. T. et al. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 5, e1000559, doi: 10.1371/journal.ppat.1000559 (2009). · DOI · Paper page
  8. Ito, M. et al. Bruton’s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury. Nature communications 6, 7360, doi: 10.1038/ncomms8360 (2015). · DOI · Paper page
  9. Chuang, Y. T. et al. Tumor suppressor death-associated protein kinase is required for full IL-1beta production. Blood 117, 960–970, doi: 10.1182/blood-2010-08-303115 (2011). · DOI · Paper page
  10. Spalinger, M. R. et al. NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22. J Clin Invest 126, 1783–1800, doi: 10.1172/JCI83669 (2016). · DOI · Paper page
  11. Neumann, K. & Ruland, J. Kinases conquer the inflammasomes. Nat Immunol 14, 1207–1208, doi: 10.1038/ni.2763 (2013). · DOI
  12. Schaller, M. D. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J Cell Sci 123, 1007–1013, doi: 10.1242/jcs.045112 (2010). · DOI · Paper page
  13. Chapman, N. M. & Houtman, J. C. Functions of the FAK family kinases in T cells: beyond actin cytoskeletal rearrangement. Immunologic research 59, 23–34, doi: 10.1007/s12026-014-8527-y (2014). · DOI · Paper page
  14. Chen, L. C. et al. Tumour inflammasome-derived IL-1beta recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma. EMBO Mol Med 4, 1276–1293, doi: 10.1002/emmm.201201569 (2012). · DOI · Paper page
  15. Wang, L. J. et al. Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated absence in melanoma 2 (AIM2) inflammasomes. Mol Cell Proteomics 11, 1230–1244, doi: 10.1074/mcp.M112.020594 (2012). · DOI
  16. Wu, Y. H. et al. Participation of c-FLIP in NLRP3 and AIM2 inflammasome activation. Cell death and differentiation 21, 451–461, doi: 10.1038/cdd.2013.165 (2014). · DOI
  17. Schmidt, F. I. et al. A single domain antibody fragment that recognizes the adaptor ASC defines the role of ASC domains in inflammasome assembly. J Exp Med 213, 771–790, doi: 10.1084/jem.20151790 (2016). · DOI · Paper page
  18. Dick, M. S., Sborgi, L., Ruhl, S., Hiller, S. & Broz, P. ASC filament formation serves as a signal amplification mechanism for inflammasomes. Nature communications 7, 11929, doi: 10.1038/ncomms11929 (2016). · DOI · Paper page
  19. Abshire, M. Y., Thomas, K. S., Owen, K. A. & Bouton, A. H. Macrophage motility requires distinct alpha5beta1/FAK and alpha4beta1/paxillin signaling events. J Leukoc Biol 89, 251–257, doi: 10.1189/jlb.0710395 (2011). · DOI
  20. Misawa, T. et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol 14, 454–460, doi: 10.1038/ni.2550 (2013). · DOI · Paper page
  21. Wang, L. J. et al. The microtubule-associated protein EB1 links AIM2 inflammasomes with autophagy-dependent secretion. J Biol Chem 289, 29322–29333, doi: 10.1074/jbc.M114.559153 (2014). · DOI · Paper page
  22. Wen, Y. et al. EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat Cell Biol 6, 820–830, doi: 10.1038/ncb1160 (2004). · DOI · Paper page
  23. Kumar, S. et al. Cdc42 regulates neutrophil migration via crosstalk between WASp, CD11b, and microtubules. Blood 120, 3563–3574, doi: 10.1182/blood-2012-04-426981 (2012). · DOI · Paper page
  24. Watanabe, T. et al. TTBK2 with EB1/3 regulates microtubule dynamics in migrating cells through KIF2A phosphorylation. J Cell Biol 210, 737–751, doi: 10.1083/jcb.201412075 (2015). · DOI · Paper page
  25. Cheung, R., Ravyn, V., Wang, L., Ptasznik, A. & Collman, R. G. Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. J Immunol 180, 6675–6684 (2008). · DOI
  26. Wang, L. et al. ‘Tuning’ of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages. Nat Immunol 9, 186–193, doi: 10.1038/ni1548 (2008). · DOI
  27. Lee, B. Y., Timpson, P., Horvath, L. G. & Daly, R. J. FAK signaling in human cancer as a target for therapeutics. Pharmacol Ther 146, 132–149, doi: 10.1016/j.pharmthera.2014.10.001 (2015). · DOI · Paper page
  28. Lin, J. C. et al. Sorafenib induces autophagy and suppresses activation of human macrophage. International immunopharmacology 15, 333–339, doi: 10.1016/j.intimp.2013.01.006 (2013). · DOI

Cited by

See all 89

Metadata

Authors
Chung, I.-C., OuYang, C.-N., Yuan, S.-N., Li, H.-P., Chen, J.-T., Shieh, H.-R., Chen, Y.-J., Ojcius, D. M., Chu, C.-L., Yu, J.-S., Chang, Y.-S., & Chen, L.-C.
Venue
Scientific Reports
Published
2016-10-31
Volume
6
Issue
1
ISSN
2045-2322
Cited by
89
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.